BioRemind IVS: Financial statements 2017
CVR: 36733241
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
BioRemind IVS (CVR 36733241) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -4,982 and a net result of DKK -5,590 compared with DKK -11,183 the year before. Equity in the 2017 report amounted to DKK 785. The solvency ratio was 2.8%.
- Gross Profit
- DKK -4,982
- Profit/Loss
- DKK -5,590
- Equity
- DKK 785
- Total Assets
- DKK 28,285
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | -5 t. | -6 t. | 785 | - |
| 2016 | - | -10 t. | -11 t. | -24 t. | - |
Official annual report
Keep an eye on BioRemind IVS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
BioRemind IVS has published its annual report for 2016. Gross profit came to DKK -10,334, and the net result was DKK -11,183.
About BioRemind IVS
BioRemind IVS was a Danish company of the type Iværksætterselskab based in Aarhus N, founded in 2015. The company has been dissolved on 20 February 2021. The company was registered under the industry Anden udgivelse af software. In 2019, the company reported a gross profit of DKK -2,609 and a net result of DKK -2,609 compared with DKK -6,789 the year before. Equity in the 2019 report amounted to DKK -8,613.